Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Antoni Torres Marti (Barcelona, Spain). How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?. International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients

Member's Comments

No comment yet.

Related content which might interest you: Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 106s Year: 2006 Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)? Source: Eur Respir J 2003; 22: Suppl. 45, 338s Year: 2003 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Bacterial infections in patients with acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 Polypharmacy in patients hospitalised for acute exacerbation of COPD Source: Eur Respir J 2014; 44: 791-794 Year: 2014 Infective etiology of acute exacerbation of COPD (AECOPD) Source: Eur Respir J 2004; 24: Suppl. 48, 512s Year: 2004 The validity of the EQ5D5L in patients hospitalized an acute exacerbation of COPD Source: International Congress 2017 – Latest insights into chronic care Year: 2017 The role of viral infections in patients admitted with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 Quantification of severity of the acute exacerbation in hospitalized COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003